Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of CDK5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2342.12 | 2641 / 2642 | 100% | 51.33 | 705 / 705 |
adrenal gland | 100% | 1075.22 | 258 / 258 | 100% | 41.49 | 229 / 230 |
skin | 99% | 653.14 | 1799 / 1809 | 100% | 53.90 | 472 / 472 |
kidney | 99% | 572.84 | 88 / 89 | 99% | 25.50 | 893 / 901 |
stomach | 99% | 418.97 | 355 / 359 | 99% | 25.33 | 283 / 286 |
liver | 98% | 402.03 | 222 / 226 | 100% | 23.21 | 404 / 406 |
intestine | 98% | 450.01 | 948 / 966 | 99% | 28.53 | 521 / 527 |
thymus | 97% | 461.81 | 631 / 653 | 100% | 24.10 | 604 / 605 |
prostate | 96% | 453.91 | 235 / 245 | 99% | 27.61 | 497 / 502 |
bladder | 95% | 393.00 | 20 / 21 | 98% | 29.99 | 496 / 504 |
breast | 94% | 362.57 | 432 / 459 | 99% | 32.09 | 1107 / 1118 |
uterus | 93% | 371.44 | 158 / 170 | 100% | 32.01 | 458 / 459 |
esophagus | 97% | 450.44 | 1402 / 1445 | 95% | 14.66 | 173 / 183 |
pancreas | 88% | 261.12 | 290 / 328 | 99% | 23.90 | 176 / 178 |
lung | 87% | 409.92 | 505 / 578 | 99% | 26.13 | 1144 / 1155 |
ovary | 67% | 171.02 | 120 / 180 | 100% | 32.19 | 430 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 33.89 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.66 | 29 / 29 |
spleen | 100% | 640.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.24 | 1 / 1 |
adipose | 93% | 335.15 | 1125 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 338.92 | 1207 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 579.39 | 824 / 929 | 0% | 0 | 0 / 0 |
heart | 84% | 275.43 | 727 / 861 | 0% | 0 | 0 / 0 |
muscle | 72% | 207.26 | 577 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0021819 | Biological process | layer formation in cerebral cortex |
GO_0051301 | Biological process | cell division |
GO_0001764 | Biological process | neuron migration |
GO_0043113 | Biological process | receptor clustering |
GO_0070509 | Biological process | calcium ion import |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0061001 | Biological process | regulation of dendritic spine morphogenesis |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0030334 | Biological process | regulation of cell migration |
GO_0045956 | Biological process | positive regulation of calcium ion-dependent exocytosis |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0001963 | Biological process | synaptic transmission, dopaminergic |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0006468 | Biological process | protein phosphorylation |
GO_0048511 | Biological process | rhythmic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0019233 | Biological process | sensory perception of pain |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0031175 | Biological process | neuron projection development |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0031914 | Biological process | negative regulation of synaptic plasticity |
GO_0008542 | Biological process | visual learning |
GO_0030182 | Biological process | neuron differentiation |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0090314 | Biological process | positive regulation of protein targeting to membrane |
GO_0021954 | Biological process | central nervous system neuron development |
GO_0021697 | Biological process | cerebellar cortex formation |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0032801 | Biological process | receptor catabolic process |
GO_0046826 | Biological process | negative regulation of protein export from nucleus |
GO_0021766 | Biological process | hippocampus development |
GO_0048813 | Biological process | dendrite morphogenesis |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0007409 | Biological process | axonogenesis |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0022038 | Biological process | corpus callosum development |
GO_0048675 | Biological process | axon extension |
GO_1903421 | Biological process | regulation of synaptic vesicle recycling |
GO_0016310 | Biological process | phosphorylation |
GO_0007416 | Biological process | synapse assembly |
GO_0035418 | Biological process | protein localization to synapse |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0006886 | Biological process | intracellular protein transport |
GO_0016079 | Biological process | synaptic vesicle exocytosis |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0014044 | Biological process | Schwann cell development |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0008045 | Biological process | motor neuron axon guidance |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_0048148 | Biological process | behavioral response to cocaine |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0048489 | Biological process | synaptic vesicle transport |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0016533 | Cellular component | protein kinase 5 complex |
GO_0098793 | Cellular component | presynapse |
GO_0043025 | Cellular component | neuronal cell body |
GO_0043005 | Cellular component | neuron projection |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
GO_0030175 | Cellular component | filopodium |
GO_0030027 | Cellular component | lamellipodium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005874 | Cellular component | microtubule |
GO_0016020 | Cellular component | membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0005829 | Cellular component | cytosol |
GO_0030426 | Cellular component | growth cone |
GO_0030054 | Cellular component | cell junction |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0005176 | Molecular function | ErbB-2 class receptor binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043125 | Molecular function | ErbB-3 class receptor binding |
GO_0030549 | Molecular function | acetylcholine receptor activator activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0005515 | Molecular function | protein binding |
GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
GO_0008017 | Molecular function | microtubule binding |
GO_0016301 | Molecular function | kinase activity |
Gene name | CDK5 |
Protein name | Cell division protein kinase 5 Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) |
Synonyms | PSSALRE CDKN5 hCG_18690 tcag7.772 |
Description | FUNCTION: Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Phosphorylates SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocyte differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. Negatively regulates the CACNA1B/CAV2.2 -mediated Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity). Activated by interaction with CDK5R1 (p35) and CDK5R2 (p39), especially in postmitotic neurons, and promotes CDK5R1 (p35) expression in an autostimulation loop. Phosphorylates many downstream substrates such as Rho and Ras family small GTPases (e.g. PAK1, RAC1, RHOA, CDC42) or microtubule-binding proteins (e.g. MAPT/TAU, MAP2, MAP1B), and modulates actin dynamics to regulate neurite growth and/or spine morphogenesis. Phosphorylates also exocytosis associated proteins such as MCAM/MUC18, SEPT5, SYN1, and CDK16/PCTAIRE1 as well as endocytosis associated proteins such as DNM1, AMPH and SYNJ1 at synaptic terminals. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. Promotes cell survival by activating anti-apoptotic proteins BCL2 and STAT3, and negatively regulating of JNK3/MAPK10 activity. Phosphorylation of p53/TP53 in response to genotoxic and oxidative stresses enhances its stabilization by preventing ubiquitin ligase-mediated proteasomal degradation, and induces transactivation of p53/TP53 target genes, thus regulating apoptosis. Phosphorylation of p35/CDK5R1 enhances its stabilization by preventing calpain-mediated proteolysis producing p25/CDK5R1 and avoiding ubiquitin ligase-mediated proteasomal degradation. During aberrant cell-cycle activity and DNA damage, p25/CDK5 activity elicits cell-cycle activity and double-strand DNA breaks that precedes neuronal death by deregulating HDAC1. DNA damage triggered phosphorylation of huntingtin/HTT in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. Phosphorylation of PXN reduces its interaction with PTK2/FAK1 in matrix-cell focal adhesions (MCFA) during oligodendrocytes (OLs) differentiation. Negative regulator of Wnt/beta-catenin signaling pathway. Activator of the GAIT (IFN-gamma-activated inhibitor of translation) pathway, which suppresses expression of a post-transcriptional regulon of proinflammatory genes in myeloid cells; phosphorylates the linker domain of glutamyl-prolyl tRNA synthetase (EPRS) in a IFN-gamma-dependent manner, the initial event in assembly of the GAIT complex. Phosphorylation of SH3GLB1 is required for autophagy induction in starved neurons. Phosphorylation of TONEBP/NFAT5 in response to osmotic stress mediates its rapid nuclear localization. MEF2 is inactivated by phosphorylation in nucleus in response to neurotoxin, thus leading to neuronal apoptosis. APEX1 AP-endodeoxyribonuclease is repressed by phosphorylation, resulting in accumulation of DNA damage and contributing to neuronal death. NOS3 phosphorylation down regulates NOS3-derived nitrite (NO) levels. SRC phosphorylation mediates its ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-BMAL1 heterodimer in association with altered stability and subcellular distribution. . |
Accessions | A0A0S2Z355 A0A090N7W4 Q6IAW3 ENST00000485972.6 [Q00535-1] ENST00000297518.4 [Q00535-2] Q00535 |